Proactiveinvestors United Kingdom Scancell Holdings PLC https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom Scancell Holdings PLC RSS feed en Wed, 20 Nov 2019 05:10:02 +0000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Scancell exploring new frontiers in cancer research https://www.proactiveinvestors.co.uk/companies/news/220600/scancell-exploring-new-frontiers-in-cancer-research-220600.html Tue, 12 Nov 2019 06:51:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/220600/scancell-exploring-new-frontiers-in-cancer-research-220600.html Scancell Holdings appoints new independent director https://www.proactiveinvestors.co.uk/companies/news/905403/scancell-holdings-appoints-new-independent-director-905403.html Wed, 23 Oct 2019 06:22:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/905403/scancell-holdings-appoints-new-independent-director-905403.html Antibody collaboration deal for Scancell https://www.proactiveinvestors.co.uk/companies/news/902103/antibody-collaboration-deal-for-scancell-902103.html Thu, 05 Sep 2019 07:47:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/902103/antibody-collaboration-deal-for-scancell-902103.html Scancell hails first antibody collaboration deal https://www.proactiveinvestors.co.uk/companies/news/902000/scancell-hails-first-antibody-collaboration-deal-902000.html Wed, 04 Sep 2019 06:55:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/902000/scancell-hails-first-antibody-collaboration-deal-902000.html Scancell Holdings lays groundwork for pivotal year https://www.proactiveinvestors.co.uk/companies/news/901102/scancell-holdings-lays-groundwork-for-pivotal-year-901102.html Tue, 20 Aug 2019 07:05:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901102/scancell-holdings-lays-groundwork-for-pivotal-year-901102.html Scancell back in the clinic with a phase II trial of its flagship skin cancer treatment https://www.proactiveinvestors.co.uk/companies/news/901043/scancell-back-in-the-clinic-with-a-phase-ii-trial-of-its-flagship-skin-cancer-treatment-901043.html Mon, 19 Aug 2019 12:32:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901043/scancell-back-in-the-clinic-with-a-phase-ii-trial-of-its-flagship-skin-cancer-treatment-901043.html Scancell to begin UK arm of phase II skin cancer trial ‘immediately’ https://www.proactiveinvestors.co.uk/companies/news/901014/scancell-to-begin-uk-arm-of-phase-ii-skin-cancer-trial-immediately-901014.html Mon, 19 Aug 2019 07:46:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901014/scancell-to-begin-uk-arm-of-phase-ii-skin-cancer-trial-immediately-901014.html Scancell on verge of recruiting patients with advanced melanoma for UK clinical trials https://www.proactiveinvestors.co.uk/companies/news/223113/scancell-on-verge-of-recruiting-patients-with-advanced-melanoma-for-uk-clinical-trials-223113.html Mon, 01 Jul 2019 12:19:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/223113/scancell-on-verge-of-recruiting-patients-with-advanced-melanoma-for-uk-clinical-trials-223113.html Vulpes Life Sciences Fund's Martin Diggle discusses Scancell investment https://www.proactiveinvestors.co.uk/companies/news/313831/vulpes-life-sciences-fund-s-martin-diggle-discusses-scancell-investment-13831.html Fri, 21 Jun 2019 09:21:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/313831/vulpes-life-sciences-fund-s-martin-diggle-discusses-scancell-investment-13831.html Scancell welcomes strategic new investor Vulpes Life Sciences Fund https://www.proactiveinvestors.co.uk/companies/news/313724/scancell-welcomes-strategic-new-investor-vulpes-life-sciences-fund-13724.html Thu, 13 Jun 2019 10:53:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/313724/scancell-welcomes-strategic-new-investor-vulpes-life-sciences-fund-13724.html Scancell raises £3.9mln to advance immunotherapy product pipeline https://www.proactiveinvestors.co.uk/companies/news/222043/scancell-raises-39mln-to-advance-immunotherapy-product-pipeline-222043.html Thu, 13 Jun 2019 07:31:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/222043/scancell-raises-39mln-to-advance-immunotherapy-product-pipeline-222043.html Scancell surges after announcing milestone in development of its solid tumours treatment https://www.proactiveinvestors.co.uk/companies/news/220580/scancell-surges-after-announcing-milestone-in-development-of-its-solid-tumours-treatment-220580.html Mon, 20 May 2019 07:23:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/220580/scancell-surges-after-announcing-milestone-in-development-of-its-solid-tumours-treatment-220580.html Scancell adds six ‘world-leading’ cancer specialists to advisory board ahead of Modi-1 trial https://www.proactiveinvestors.co.uk/companies/news/220030/scancell-adds-six-world-leading-cancer-specialists-to-advisory-board-ahead-of-modi-1-trial-220030.html Fri, 10 May 2019 06:45:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/220030/scancell-adds-six-world-leading-cancer-specialists-to-advisory-board-ahead-of-modi-1-trial-220030.html Scancell higher as it is to begin UK arm of phase II skin cancer trial within weeks https://www.proactiveinvestors.co.uk/companies/news/219074/scancell-higher-as-it-is-to-begin-uk-arm-of-phase-ii-skin-cancer-trial-within-weeks-219074.html Thu, 25 Apr 2019 13:20:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/219074/scancell-higher-as-it-is-to-begin-uk-arm-of-phase-ii-skin-cancer-trial-within-weeks-219074.html Scancell to begin dosing in UK phase II trial of flagship skin cancer drug https://www.proactiveinvestors.co.uk/companies/news/313102/scancell-to-begin-dosing-in-uk-phase-ii-trial-of-flagship-skin-cancer-drug-13102.html Thu, 25 Apr 2019 11:56:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/313102/scancell-to-begin-dosing-in-uk-phase-ii-trial-of-flagship-skin-cancer-drug-13102.html Scancell Holdings wins Japanese patent protection https://www.proactiveinvestors.co.uk/companies/news/218116/scancell-holdings-wins-japanese-patent-protection-218116.html Mon, 08 Apr 2019 09:20:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/218116/scancell-holdings-wins-japanese-patent-protection-218116.html Scancell strengthens IP with two “important” patent grants in US and Europe https://www.proactiveinvestors.co.uk/companies/news/216814/scancell-strengthens-ip-with-two-important-patent-grants-in-us-and-europe-216814.html Wed, 20 Mar 2019 07:55:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/216814/scancell-strengthens-ip-with-two-important-patent-grants-in-us-and-europe-216814.html Scancell in vanguard of immuno-oncology advances, with two technologies that show early promise https://www.proactiveinvestors.co.uk/companies/news/214474/scancell-in-vanguard-of-immuno-oncology-advances-with-two-technologies-that-show-early-promise-214474.html Tue, 12 Feb 2019 15:07:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/214474/scancell-in-vanguard-of-immuno-oncology-advances-with-two-technologies-that-show-early-promise-214474.html Scancell lauds another six months of progress https://www.proactiveinvestors.co.uk/companies/news/213702/scancell-lauds-another-six-months-of-progress-213702.html Thu, 31 Jan 2019 08:41:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/213702/scancell-lauds-another-six-months-of-progress-213702.html Award shortlist 'a significant scientific endorsement' of Scancell's technology https://www.proactiveinvestors.co.uk/companies/news/311959/award-shortlist--a-significant-scientific-endorsement--of-scancell-s-technology-11959.html Wed, 23 Jan 2019 12:25:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/311959/award-shortlist--a-significant-scientific-endorsement--of-scancell-s-technology-11959.html Scancell receives “significant scientific endorsement” for technology https://www.proactiveinvestors.co.uk/companies/news/213126/scancell-receives-significant-scientific-endorsement-for-technology-213126.html Wed, 23 Jan 2019 07:27:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/213126/scancell-receives-significant-scientific-endorsement-for-technology-213126.html Scancell hires two industry veterans as it gears up for the next development phase https://www.proactiveinvestors.co.uk/companies/news/212933/scancell-hires-two-industry-veterans-as-it-gears-up-for-the-next-development-phase-212933.html Mon, 21 Jan 2019 07:29:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/212933/scancell-hires-two-industry-veterans-as-it-gears-up-for-the-next-development-phase-212933.html Scancell’s Modi-2 anti-cancer vaccine shows potential in pre-clinical studies https://www.proactiveinvestors.co.uk/companies/news/208085/scancells-modi-2-anti-cancer-vaccine-shows-potential-in-pre-clinical-studies-208085.html Tue, 30 Oct 2018 14:05:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/208085/scancells-modi-2-anti-cancer-vaccine-shows-potential-in-pre-clinical-studies-208085.html Scancell says it is working closely with US regulators ahead of phase II study of cancer immunotherapy https://www.proactiveinvestors.co.uk/companies/news/207727/scancell-says-it-is-working-closely-with-us-regulators-ahead-of-phase-ii-study-of-cancer-immunotherapy-207727.html Wed, 24 Oct 2018 06:40:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/207727/scancell-says-it-is-working-closely-with-us-regulators-ahead-of-phase-ii-study-of-cancer-immunotherapy-207727.html Scancell Holdings part of the new cancer revolution https://www.proactiveinvestors.co.uk/companies/news/202582/scancell-holdings-part-of-the-new-cancer-revolution-202582.html Tue, 25 Sep 2018 07:20:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/202582/scancell-holdings-part-of-the-new-cancer-revolution-202582.html Scancell Holdings extends collaboration with Sweden's Karolinska Institute https://www.proactiveinvestors.co.uk/companies/news/202553/scancell-holdings-extends-collaboration-with-sweden-s-karolinska-institute-202553.html Thu, 09 Aug 2018 09:15:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/202553/scancell-holdings-extends-collaboration-with-sweden-s-karolinska-institute-202553.html Scancell Holdings inks drug delivery technology deal https://www.proactiveinvestors.co.uk/companies/news/201021/scancell-holdings-inks-drug-delivery-technology-deal-201021.html Wed, 18 Jul 2018 07:09:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/201021/scancell-holdings-inks-drug-delivery-technology-deal-201021.html Scancell receives European patent protection for immunotherapy platform https://www.proactiveinvestors.co.uk/companies/news/197507/scancell-receives-european-patent-protection-for-immunotherapy-platform-197507.html Wed, 23 May 2018 06:28:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/197507/scancell-receives-european-patent-protection-for-immunotherapy-platform-197507.html Scancell unveils funding plans for exciting pipeline of next-generation cancer drugs https://www.proactiveinvestors.co.uk/companies/news/195228/scancell-unveils-funding-plans-for-exciting-pipeline-of-next-generation-cancer-drugs-195228.html Wed, 18 Apr 2018 14:15:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/195228/scancell-unveils-funding-plans-for-exciting-pipeline-of-next-generation-cancer-drugs-195228.html Scancell to raise up to £8mln to develop its three main drug candidates https://www.proactiveinvestors.co.uk/companies/news/309091/scancell-to-raise-up-to-8mln-to-develop-its-three-main-drug-candidates-9091.html Wed, 18 Apr 2018 13:18:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/309091/scancell-to-raise-up-to-8mln-to-develop-its-three-main-drug-candidates-9091.html Scancell signs manufacturing agreement for its Moditope anti-cancer platform https://www.proactiveinvestors.co.uk/companies/news/194118/scancell-signs-manufacturing-agreement-for-its-moditope-anti-cancer-platform-194118.html Tue, 03 Apr 2018 06:40:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/194118/scancell-signs-manufacturing-agreement-for-its-moditope-anti-cancer-platform-194118.html Scancell to work with Dutch firm on first product for Moditope cancer immuno-therapy platform https://www.proactiveinvestors.co.uk/companies/news/191691/scancell-to-work-with-dutch-firm-on-first-product-for-moditope-cancer-immuno-therapy-platform-191691.html Thu, 15 Feb 2018 15:00:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/191691/scancell-to-work-with-dutch-firm-on-first-product-for-moditope-cancer-immuno-therapy-platform-191691.html New Scancell chief sets out his vision to commercialise groundbreaking cancer treatments https://www.proactiveinvestors.co.uk/companies/news/308748/new-scancell-chief-sets-out-his-vision-to-commercialise-groundbreaking-cancer-treatments-8748.html Thu, 15 Feb 2018 12:38:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/308748/new-scancell-chief-sets-out-his-vision-to-commercialise-groundbreaking-cancer-treatments-8748.html Scancell drug receives positive write-up in leading journal as company updates on survival data https://www.proactiveinvestors.co.uk/companies/news/191494/scancell-drug-receives-positive-write-up-in-leading-journal-as-company-updates-on-survival-data-191494.html Mon, 12 Feb 2018 11:50:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/191494/scancell-drug-receives-positive-write-up-in-leading-journal-as-company-updates-on-survival-data-191494.html Scancell to receive patent protection for key cancer platform https://www.proactiveinvestors.co.uk/companies/news/191435/scancell-to-receive-patent-protection-for-key-cancer-platform-191435.html Fri, 09 Feb 2018 07:30:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/191435/scancell-to-receive-patent-protection-for-key-cancer-platform-191435.html Scancell-led team short-listed for award https://www.proactiveinvestors.co.uk/companies/news/191358/scancell-led-team-short-listed-for-award-191358.html Thu, 08 Feb 2018 08:00:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/191358/scancell-led-team-short-listed-for-award-191358.html Scancell eyeing investigational new drug application for SCIB1 in first half https://www.proactiveinvestors.co.uk/companies/news/190808/scancell-eyeing-investigational-new-drug-application-for-scib1-in-first-half-190808.html Tue, 30 Jan 2018 07:58:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/190808/scancell-eyeing-investigational-new-drug-application-for-scib1-in-first-half-190808.html Scancell poised for “significant” year with its immuno-oncology portfolio https://www.proactiveinvestors.co.uk/companies/news/172364/scancell-poised-for-significant-year-with-its-immuno-oncology-portfolio-172364.html Mon, 15 Jan 2018 10:30:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/172364/scancell-poised-for-significant-year-with-its-immuno-oncology-portfolio-172364.html Scancell research collaboration deal with European biopharma BioNTech https://www.proactiveinvestors.co.uk/companies/news/308611/scancell-research-collaboration-deal-with-european-biopharma-biontech-8611.html Fri, 12 Jan 2018 12:13:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/308611/scancell-research-collaboration-deal-with-european-biopharma-biontech-8611.html Scancell inks research collaboration deal with European biopharma BioNTech https://www.proactiveinvestors.co.uk/companies/news/189708/scancell-inks-research-collaboration-deal-with-european-biopharma-biontech-189708.html Tue, 09 Jan 2018 07:51:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/189708/scancell-inks-research-collaboration-deal-with-european-biopharma-biontech-189708.html Cancer Research UK collaboration 'a stunning endorsement' for Scancell https://www.proactiveinvestors.co.uk/companies/news/308540/cancer-research-uk-collaboration-a-stunning-endorsement-for-scancell-8540.html Thu, 14 Dec 2017 13:21:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/308540/cancer-research-uk-collaboration-a-stunning-endorsement-for-scancell-8540.html Scancell soars as it confirms Cancer Research UK to fund and sponsor SCIB2 clinical trial https://www.proactiveinvestors.co.uk/companies/news/188800/scancell-soars-as-it-confirms-cancer-research-uk-to-fund-and-sponsor-scib2-clinical-trial-188800.html Thu, 14 Dec 2017 11:06:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/188800/scancell-soars-as-it-confirms-cancer-research-uk-to-fund-and-sponsor-scib2-clinical-trial-188800.html Scancell recruits deal maker to take over as CEO https://www.proactiveinvestors.co.uk/companies/news/185329/scancell-recruits-deal-maker-to-take-over-as-ceo-185329.html Tue, 10 Oct 2017 09:24:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/185329/scancell-recruits-deal-maker-to-take-over-as-ceo-185329.html Scancell on the lookout for partners after year of “significant progress” https://www.proactiveinvestors.co.uk/companies/news/183895/scancell-on-the-lookout-for-partners-after-year-of-significant-progress-183895.html Wed, 13 Sep 2017 07:21:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/183895/scancell-on-the-lookout-for-partners-after-year-of-significant-progress-183895.html Scancell presents Moditope data at prestigious cancer conference https://www.proactiveinvestors.co.uk/companies/news/183752/scancell-presents-moditope-data-at-prestigious-cancer-conference-183752.html Mon, 11 Sep 2017 10:25:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/183752/scancell-presents-moditope-data-at-prestigious-cancer-conference-183752.html Scancell says study reveals Oncimmune technology may assist in its SCIB1 cancer treatment https://www.proactiveinvestors.co.uk/companies/news/183083/scancell-says-study-reveals-oncimmune-technology-may-assist-in-its-scib1-cancer-treatment-183083.html Tue, 29 Aug 2017 14:35:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/183083/scancell-says-study-reveals-oncimmune-technology-may-assist-in-its-scib1-cancer-treatment-183083.html Scancell’s SCIB1 cancer treatment continues to produce strong survival data https://www.proactiveinvestors.co.uk/companies/news/180668/scancells-scib1-cancer-treatment-continues-to-produce-strong-survival-data-180668.html Tue, 11 Jul 2017 06:58:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/180668/scancells-scib1-cancer-treatment-continues-to-produce-strong-survival-data-180668.html Scancell technology receives European patent protection https://www.proactiveinvestors.co.uk/companies/news/179796/scancell-technology-receives-european-patent-protection-179796.html Mon, 26 Jun 2017 06:47:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/179796/scancell-technology-receives-european-patent-protection-179796.html Scancell raises £5mln in 'most successful round they've ever had' - CEO Richard Goodfellow https://www.proactiveinvestors.co.uk/companies/news/307443/scancell-raises-5mln-in-most-successful-round-they-ve-ever-had-ceo-richard-goodfellow-7443.html Fri, 12 May 2017 08:57:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/307443/scancell-raises-5mln-in-most-successful-round-they-ve-ever-had-ceo-richard-goodfellow-7443.html Scancell Holdings raises £5mln as pace of clinical work quickens https://www.proactiveinvestors.co.uk/companies/news/177639/scancell-holdings-raises-5mln-as-pace-of-clinical-work-quickens-177639.html Thu, 11 May 2017 13:00:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/177639/scancell-holdings-raises-5mln-as-pace-of-clinical-work-quickens-177639.html Scancell boss 'very excited' about collaboration deal with leading US lung cancer foundation https://www.proactiveinvestors.co.uk/companies/news/306826/scancell-boss-very-excited-about-collaboration-deal-with-leading-us-lung-cancer-foundation-6826.html Wed, 01 Feb 2017 09:53:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/306826/scancell-boss-very-excited-about-collaboration-deal-with-leading-us-lung-cancer-foundation-6826.html Scancell rounds up a busy six months https://www.proactiveinvestors.co.uk/companies/news/172397/scancell-rounds-up-a-busy-six-months-172397.html Tue, 31 Jan 2017 08:01:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/172397/scancell-rounds-up-a-busy-six-months-172397.html Scancell inks collaboration deal with leading US lung cancer foundation https://www.proactiveinvestors.co.uk/companies/news/172338/scancell-inks-collaboration-deal-with-leading-us-lung-cancer-foundation-172338.html Mon, 30 Jan 2017 07:39:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/172338/scancell-inks-collaboration-deal-with-leading-us-lung-cancer-foundation-172338.html Scancell "very optimistic" about US study after "compelling" melanoma trial results https://www.proactiveinvestors.co.uk/companies/news/306674/scancell-very-optimistic-about-us-study-after-compelling-melanoma-trial-results-6674.html Wed, 04 Jan 2017 12:08:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/306674/scancell-very-optimistic-about-us-study-after-compelling-melanoma-trial-results-6674.html Scancell hails "compelling" results from clinical trial https://www.proactiveinvestors.co.uk/companies/news/171077/scancell-hails-compelling-results-from-clinical-trial-171077.html Tue, 03 Jan 2017 12:15:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/171077/scancell-hails-compelling-results-from-clinical-trial-171077.html Scancell up 7% after lung cancer announcement https://www.proactiveinvestors.co.uk/companies/news/167132/scancell-up-7-after-lung-cancer-announcement-167132.html Mon, 10 Oct 2016 15:05:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/167132/scancell-up-7-after-lung-cancer-announcement-167132.html Scancell boss “very optimistic” about latest drug candidate https://www.proactiveinvestors.co.uk/companies/news/306152/scancell-boss-very-optimistic-about-latest-drug-candidate-6152.html Mon, 10 Oct 2016 14:30:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/306152/scancell-boss-very-optimistic-about-latest-drug-candidate-6152.html Scancell wants to take more discoveries into the clinic https://www.proactiveinvestors.co.uk/companies/news/165993/scancell-wants-to-take-more-discoveries-into-the-clinic-165993.html Fri, 16 Sep 2016 06:38:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/165993/scancell-wants-to-take-more-discoveries-into-the-clinic-165993.html Scancell adds heavy hitter to board https://www.proactiveinvestors.co.uk/companies/news/129548/scancell-adds-heavy-hitter-to-board-129548.html Mon, 22 Aug 2016 07:35:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/129548/scancell-adds-heavy-hitter-to-board-129548.html Scancell ever closer to tackling most deadly form of cancer https://www.proactiveinvestors.co.uk/companies/news/127911/scancell-ever-closer-to-tackling-most-deadly-form-of-cancer-127911.html Thu, 21 Jul 2016 10:20:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/127911/scancell-ever-closer-to-tackling-most-deadly-form-of-cancer-127911.html Scancell turns to Belgian group to replenish vaccine stocks https://www.proactiveinvestors.co.uk/companies/news/128453/scancell-turns-to-belgian-group-to-replenish-vaccine-stocks-128453.html Thu, 21 Jul 2016 07:38:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/128453/scancell-turns-to-belgian-group-to-replenish-vaccine-stocks-128453.html Scancell says Ichor deal extension “clears the runway” https://www.proactiveinvestors.co.uk/companies/news/305302/scancell-says-ichor-deal-extension-clears-the-runway-5302.html Wed, 20 Jul 2016 15:31:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/305302/scancell-says-ichor-deal-extension-clears-the-runway-5302.html Scancell extends commercial licence with Ichor https://www.proactiveinvestors.co.uk/companies/news/128383/scancell-extends-commercial-licence-with-ichor-128383.html Wed, 20 Jul 2016 06:19:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/128383/scancell-extends-commercial-licence-with-ichor-128383.html Scancell’s cancer vaccine programme boosted by scientific review https://www.proactiveinvestors.co.uk/companies/news/128135/scancells-cancer-vaccine-programme-boosted-by-scientific-review-128135.html Wed, 13 Jul 2016 06:25:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/128135/scancells-cancer-vaccine-programme-boosted-by-scientific-review-128135.html Scancell Holdings says SCIB1 survival data is compelling https://www.proactiveinvestors.co.uk/companies/news/127882/scancell-holdings-says-scib1-survival-data-is-compelling-127882.html Wed, 06 Jul 2016 08:31:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/127882/scancell-holdings-says-scib1-survival-data-is-compelling-127882.html Scancell working quickly to secure new supplies of drug https://www.proactiveinvestors.co.uk/companies/news/127230/scancell-working-quickly-to-secure-new-supplies-of-drug-127230.html Fri, 17 Jun 2016 14:27:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/127230/scancell-working-quickly-to-secure-new-supplies-of-drug-127230.html Scancell's SCIB1 offers patient opportunities - Panmure's Mitchell https://www.proactiveinvestors.co.uk/companies/news/305158/scancell-s-scib1-offers-patient-opportunities-panmure-s-mitchell-5158.html Fri, 17 Jun 2016 12:13:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/305158/scancell-s-scib1-offers-patient-opportunities-panmure-s-mitchell-5158.html Scancell's immunotherapy platform to fight brain cancer https://www.proactiveinvestors.co.uk/companies/news/126659/scancell-s-immunotherapy-platform-to-fight-brain-cancer-126659.html Thu, 02 Jun 2016 07:42:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/126659/scancell-s-immunotherapy-platform-to-fight-brain-cancer-126659.html Combined immunotherapies provide hope for skin cancer cure https://www.proactiveinvestors.co.uk/companies/news/126602/combined-immunotherapies-provide-hope-for-skin-cancer-cure-126602.html Wed, 01 Jun 2016 08:54:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/126602/combined-immunotherapies-provide-hope-for-skin-cancer-cure-126602.html Scancell undergoes management reshuffle https://www.proactiveinvestors.co.uk/companies/news/126071/scancell-undergoes-management-reshuffle-126071.html Wed, 18 May 2016 07:13:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/126071/scancell-undergoes-management-reshuffle-126071.html Scancell Holdings PLC brings in £6.2mln in fundraise https://www.proactiveinvestors.co.uk/companies/news/124368/scancell-holdings-plc-brings-in-62mln-in-fundraise-124368.html Mon, 04 Apr 2016 09:59:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/124368/scancell-holdings-plc-brings-in-62mln-in-fundraise-124368.html Scancell Holdings PLC 'delighted' with success of £6.1mln fundraiser https://www.proactiveinvestors.co.uk/companies/news/124304/scancell-holdings-plc-delighted-with-success-of-61mln-fundraiser-124304.html Fri, 01 Apr 2016 06:56:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/124304/scancell-holdings-plc-delighted-with-success-of-61mln-fundraiser-124304.html Scancell Holdings PLC to present at World Vaccine Congress https://www.proactiveinvestors.co.uk/companies/news/124007/scancell-holdings-plc-to-present-at-world-vaccine-congress-124007.html Wed, 23 Mar 2016 07:59:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/124007/scancell-holdings-plc-to-present-at-world-vaccine-congress-124007.html Scancell Holdings PLC’s technology underpinned by latest deal, says joint chief https://www.proactiveinvestors.co.uk/companies/news/304763/scancell-holdings-plcs-technology-underpinned-by-latest-deal-says-joint-chief-4763.html Fri, 11 Mar 2016 12:36:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/304763/scancell-holdings-plcs-technology-underpinned-by-latest-deal-says-joint-chief-4763.html Scancell Holdings PLC teams up with Sweden's leading research organisation https://www.proactiveinvestors.co.uk/companies/news/123560/scancell-holdings-plc-teams-up-with-sweden-s-leading-research-organisation-123560.html Fri, 11 Mar 2016 08:12:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/123560/scancell-holdings-plc-teams-up-with-sweden-s-leading-research-organisation-123560.html Scancell PLC in collaboration talks after funding, says joint chief https://www.proactiveinvestors.co.uk/companies/news/304760/scancell-plc-in-collaboration-talks-after-funding-says-joint-chief-4760.html Thu, 10 Mar 2016 13:34:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/304760/scancell-plc-in-collaboration-talks-after-funding-says-joint-chief-4760.html Scancell PLC fund raise well-backed as trial pace quickens https://www.proactiveinvestors.co.uk/companies/news/123475/scancell-plc-fund-raise-well-backed-as-trial-pace-quickens-123475.html Wed, 09 Mar 2016 16:04:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/123475/scancell-plc-fund-raise-well-backed-as-trial-pace-quickens-123475.html Richard Goodfellow Presents on Behalf of Scancell at the Biotech Capital Conference https://www.proactiveinvestors.co.uk/companies/news/304737/richard-goodfellow-presents-on-behalf-of-scancell-at-the-biotech-capital-conference-4737.html Tue, 08 Mar 2016 08:57:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/304737/richard-goodfellow-presents-on-behalf-of-scancell-at-the-biotech-capital-conference-4737.html Immunotherapies: "The way forward for cancer treatment" https://www.proactiveinvestors.co.uk/companies/news/122738/immunotherapies-the-way-forward-for-cancer-treatment--122738.html Fri, 19 Feb 2016 15:27:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/122738/immunotherapies-the-way-forward-for-cancer-treatment--122738.html Scancell results track its exciting transformation https://www.proactiveinvestors.co.uk/companies/news/121807/scancell-results-track-its-exciting-transformation-121807.html Wed, 27 Jan 2016 08:42:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/121807/scancell-results-track-its-exciting-transformation-121807.html Scancell to use cutting-edge diagnostic in cancer trial https://www.proactiveinvestors.co.uk/companies/news/121144/scancell-to-use-cutting-edge-diagnostic-in-cancer-trial-121144.html Mon, 11 Jan 2016 13:35:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/121144/scancell-to-use-cutting-edge-diagnostic-in-cancer-trial-121144.html Scancell's US focus underlined by change of chairman https://www.proactiveinvestors.co.uk/companies/news/121051/scancell-s-us-focus-underlined-by-change-of-chairman-121051.html Thu, 07 Jan 2016 07:31:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/121051/scancell-s-us-focus-underlined-by-change-of-chairman-121051.html Scancell hails 'ringing endorsement' of its cancer technology https://www.proactiveinvestors.co.uk/companies/news/120956/scancell-hails-ringing-endorsement-of-its-cancer-technology-120956.html Tue, 05 Jan 2016 11:31:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/120956/scancell-hails-ringing-endorsement-of-its-cancer-technology-120956.html Scancell's Goodfellow on SCIB1 phase II plans https://www.proactiveinvestors.co.uk/companies/news/304503/scancell-s-goodfellow-on-scib1-phase-ii-plans-4503.html Mon, 21 Dec 2015 07:26:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/304503/scancell-s-goodfellow-on-scib1-phase-ii-plans-4503.html Scancell unveils phase II study team https://www.proactiveinvestors.co.uk/companies/news/120630/scancell-unveils-phase-ii-study-team-120630.html Fri, 18 Dec 2015 13:02:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/120630/scancell-unveils-phase-ii-study-team-120630.html Scancell says cancer data compelling; investment to add significant value https://www.proactiveinvestors.co.uk/companies/news/116402/scancell-says-cancer-data-compelling-investment-to-add-significant-value-116402.html Tue, 20 Oct 2015 07:06:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/116402/scancell-says-cancer-data-compelling-investment-to-add-significant-value-116402.html Scancell offers a revolution in cancer treatment https://www.proactiveinvestors.co.uk/companies/news/116209/scancell-offers-a-revolution-in-cancer-treatment-116209.html Thu, 15 Oct 2015 11:18:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/116209/scancell-offers-a-revolution-in-cancer-treatment-116209.html Scancell chief hints at future Nasdaq listing https://www.proactiveinvestors.co.uk/companies/news/304273/scancell-chief-hints-at-future-nasdaq-listing-4273.html Thu, 15 Oct 2015 07:18:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/304273/scancell-chief-hints-at-future-nasdaq-listing-4273.html Ambitious Scancell makes two key new appointments https://www.proactiveinvestors.co.uk/companies/news/116202/ambitious-scancell-makes-two-key-new-appointments-116202.html Wed, 14 Oct 2015 07:35:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/116202/ambitious-scancell-makes-two-key-new-appointments-116202.html Scancell to give six presentations at key cancer conference https://www.proactiveinvestors.co.uk/companies/news/114397/scancell-to-give-six-presentations-at-key-cancer-conference-114397.html Tue, 06 Oct 2015 13:57:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/114397/scancell-to-give-six-presentations-at-key-cancer-conference-114397.html Scancell completes part 1 dosing for cancer study https://www.proactiveinvestors.co.uk/companies/news/56701/scancell-completes-part-1-dosing-for-cancer-study-66897.html Fri, 21 Mar 2014 07:30:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/56701/scancell-completes-part-1-dosing-for-cancer-study-66897.html Scancell shares rise to 2-month high on FDA orphan drug designation https://www.proactiveinvestors.co.uk/companies/news/55580/scancell-shares-rise-to-2-month-high-on-fda-orphan-drug-designation-65702.html Tue, 11 Feb 2014 12:58:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/55580/scancell-shares-rise-to-2-month-high-on-fda-orphan-drug-designation-65702.html Scancell’s clinical programme remains on track to reveal more data this year https://www.proactiveinvestors.co.uk/companies/news/51901/scancells-clinical-programme-remains-on-track-to-reveal-more-data-this-year-61685.html Tue, 01 Oct 2013 08:22:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/51901/scancells-clinical-programme-remains-on-track-to-reveal-more-data-this-year-61685.html Scancell shares tumble as it launches discounted placing https://www.proactiveinvestors.co.uk/companies/news/49376/scancell-shares-tumble-as-it-launches-discounted-placing-58807.html Tue, 09 Jul 2013 07:52:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/49376/scancell-shares-tumble-as-it-launches-discounted-placing-58807.html Scancell Holdings says latest study backs up its approach to combatting cancer https://www.proactiveinvestors.co.uk/companies/news/45896/scancell-holdings-says-latest-study-backs-up-its-approach-to-combatting-cancer-54752.html Thu, 14 Mar 2013 06:52:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/45896/scancell-holdings-says-latest-study-backs-up-its-approach-to-combatting-cancer-54752.html Scancell close to receiving Japanese patent protection for its groundbreaking technology https://www.proactiveinvestors.co.uk/companies/news/44714/scancell-close-to-receiving-japanese-patent-protection-for-its-groundbreaking-technology--53355.html Scancell Holdings (LON:SCLP), London’s best performing stock last year, is close to receiving patent approval in Japan for its ImmunoBody vaccine technology. It already has protection for its intellectual property in the US, Europe and Australia. Shares in Scancell, which specialises in cancer vaccines, have advanced 775% in the last year.

]]>
Wed, 06 Feb 2013 07:04:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/44714/scancell-close-to-receiving-japanese-patent-protection-for-its-groundbreaking-technology--53355.html
Scancell recruits final patient in melanoma trial https://www.proactiveinvestors.co.uk/companies/news/44423/scancell-recruits-final-patient-in-melanoma-trial-53000.html Tue, 29 Jan 2013 08:02:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/44423/scancell-recruits-final-patient-in-melanoma-trial-53000.html